Article
U-BIOPRED: evaluation of the value of a public-private partnership to industry.
Drug discovery today - 1 Sept 2018
Riley John H, Erpenbeck Veit J, Matthews John G, Holweg Cecile T J, Compton Christopher, Seibold Wolfgang, Higenbottam Timothy, Wagers Scott, Rowe Anthony, Myles David
Abstract excerpt
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) was initiated in the first year of the Innovative Medicines Initiative (IMI). It was an ambitious plan to tackle the understanding of asthma through an integration of clinical and multi-'omics approaches that necessitated the bringing together of industry, academic, and patient representatives because it was too large to be managed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.